S_.mary A review was carried out of the published literature on survival rates for cancer in relation to patterns of organisation of medical care, specifically treatment at specialist centres or at hospitals treating larger numbers of patients and treatment by protocol, usually within the context of a clinical trial. Centralised referral or entry to trials was frequently associated with a higher survival rate, particularly for the less common cancers, and was never found to be associated with a lower survival rate. Few (Chouillet et al., 1994) . Analyses of survival in relation to organisational factors have yet to appear from either of these studies.
In the United Kingdom, as in several other countries, the organisation of the health service is undergoing far-reaching change. A new system, such as the British one of contracts for services with demarcation between purchasers and providers of health care, can result in changes to established patterns of referral. It is essential to obtain adequate information to ensure that the patterns of medical care which are adopted are those which result in the best outcome for patients. In oncology it is particularly important to determine the effects on survival (i) of treatment at specialised centres or in smaller district hospitals and (ii) of standardisation of treatment, most commonly through participation in multicentre controlled trials.
The literature on these topics is growing at an increasing rate and is distributed through a wide range of sometimes relatively inaccessible publications. The most recent extended review of these topics (Stiller, 1992) did not cover studies published since 1990. Moreover, it has since been found that a few earlier studies had been overlooked, including a -series of papers from the cancer registry of the former German Democratic Republic (GDR) that appeared in German journals and were seldom quoted elsewhere. The purpose of the present article is to assemble as complete a collection as possible of relevant studies and to review the body of evidence thus obtained.
Materal and metbod
The starting point was the collection of reports from population-based studies assembled for the 1992 review, which was derived largely from manual searches of major English-language general medical and oncological journals and from the bibliographies in relevant articles from these journals. This process has continued, but has been supplemented in several ways.
Population-based cancer registries whose data were already Inown to have been used for such studies were asked for details of futher publications which may have been missed, together with any unpublished studies; this yielded several published papers for review but no unpublished studies were found.
Studies of patients ascertained from reasonably complete population-based cancer registries have the best chance of indicating what is happening to the total population of patients in a given geographical area, but in some countries a relatively small proportion of the population has been covered by such registries. For this reason, the scope of the review was widened to include studies using data which were not population based, notably the large surveys of patterns of care carried out in the United States (Kramer, 1981) and Italy (Liberati et al., 1983) for which the study populations consisted of patients treated at representative samples of hospitals. More recently, population-based patterns of care studies have begun in the United States using data from the SEER Program cancer registries (Harlan, 1992) , while cancer registries in several European countnres are contributing to the international 'Eurocare' study (Chouillet et al., 1994) . Analyses of survival in relation to organisational factors have yet to appear from either of these studies.
Finally, for 1984 onwards two electronic databases, Medline and Embase, were searched on the Silver Platter Cancer CD. Tables I-XI contain 32 references included on Cancer CD and already known to the author before searching began. Of these, 14 (44%) could be retrieved by a search of medical subject headings (MESH) containing at least one of the terms survival, outcome, prognosis, mortality and at least one of hospitals, protocols, cancer care facilities, referral, health services. Four additional references not previously known were found in this search, making a total of 18 publications, and these accounted for 2.8% of the total of 649 references so indexed. Extending the search to other fields or by additional keywords increased the total number of references retrieved by a much greater proportion than it did the number of relevant publications found. This is a considerably worse result than that found by Silagy (1993) in searching for randomised controlled trials in primary care and probably reflects inconsistency in allocation of keywords.
Results
Most published studies are concerned with cancers at only one or two sites. The results for adults are presented first. Table I -IX give references, numbers of patients and variables studied for sites with more than one published study, with sites in the same order as they appear in the International Classification of Diseases. Table X gives similar information for sites with only one study each. There then follows a review of the evidence relating to childhood cancers, for which details of individual studies are given in Table XI . Results quoted are taken from the original publications unless otherwise stated.
Stomach (Table I (Ward et al., 1992) . The trial patients had a higher survival rate and the difference almost attained statistical significance. However, when strict criteria of eligibility for the trial were applied, the 217 eligible patients included in the trial had a very similar survival rate to the 493 who were not included. The greatest reduction in number among the non-trial group was due to the criterion of fitness, which rendered 212 patients ineligible, over half of them because of death within 28 days of operation.
Colorectal (Table II) Hkama et al. (1989) found wide variations in survival rates for colon cancer between the 21 hospital districts of Finland in which the patients resided. Districts were classified as university and non-university, with and without a radiotherapy unit. Much of the variation in survival was attributable to differences in age and stage distribution, but when these and other variables were taken into account in multivariate analysis there was still a significant, though small, effect of type of district. The fitted 5 year relative survival rates allowing for age and stage ranged from 43% in university districts to 38% in non-university districts without a radiotherapy unit. Mohner and Slisow (1990) Lung (Table III) In a proportional hazards analysis of 1,403 patients with non-small-cell lung carcinoma in New Hampshire and Vermont, those who lived 25-49 miles from the nearest cancer centre had a non-significantly higher mortality rate ratio than the reference group living within 25 miles (1.14; 95% confidence interval 0.97-1.35, P = 0.122) and patients living (Greenberg et al., 1991 Karjalainen (1990) (Hanks et al., 1983; Lanciano et al., 1991) . When a further sample of 565 patients treated at 120 centres (of all sizes) in 1978 was compared with the 1973 extended survey, pelvic recurrence-free survival was si ntly lower than among stage II and stage III patients treated at the large centres 5 years earlier (Lanciano et al., 1991) . No differences in survival between the three study populations were quoted for stage I, and the surveys did not include stage IV. Within the 1978 survey, numbers of patients per physician, technologist or physicist at a treatment centre were unrelated to survival (Diamond et al., 1991) .
Ovary (Table VI) Among women treated at 31 Italian hospitals (Liberati et al., 1985) , survival rates were very similar for those at centres with or without specialist oncological facilities, both for stage I-II and for stage Il-IV tumours.
In a much larger, population-based series of women in the west of Scotland (Gillis et al., 1991) (Junor et al., 1994) . In a proportional hazards analysis adjusted for age and stage, patients seen initially by a gynaecologist had a significantly higher survival rate, as did those whose surgery was performed by a gynaecologist and those who were referred to a combined clinic rather than to an individual specialist post-operatively.
Platinum chemotherapy was more likely to be given to patients at combined clinics, but the survival advantage for patients seen at these clinics remained after adjustment for type of chemotherapy.
The Danish Ovarian Cancer group covers about two-thirds of the population of Denmark. The group registered 120 women with stage I-II tumours and 361 with stage III-IV who were eligible for entry in trials during 1981-84. For stage I-LI there was no difference in actuarial survival between randomised and non-randomised patients, but among stage III-IV patients those who were randomised had a significantly higher survival rate (Bertelsen, 1991) . When the comparison for stage III-IV was restricted to patients who received combination chemotherapy, which was given to all who were randomised but to only 47% of those who were not, the difference disappeared; many of the non-randomised patients were too ill to start treatment, but results were not reported for randomised patients compared with those who received treatment of any type but were not randomised.
In south-east Sweden during 1984-87, women with stage III-IV tumours had a higher survival rate if they received treatment according to the current protocol, but there was no effect of protocol on survival for stages I-II (Hogberg et al., 1993 (Nguyen et al., 1993) . In a proportional hazards analysis of a smaller series of women with stage HIC or IVA diease treated in hospitals in California and Colorado, survival rates were sigificntly higher for patients of gynaecological oncologists (Eisenkop et al., 1992) , and this was accounted for by the greater probability of optimal cytoreduction.
Prostate (Table VII) In Finland during 1970-81 the survival rate for prostate cancer varied widely between residents of the 21 hospital districts (Karjalainen, 1990) . The variation did not appear to be related to whether there was a university hospital or radiotherapy centre in the district, and after adjustment for age and extent of disease the distribution of survival rates between districts could be explained by random variation.
In the Patterns of Care Study of men treated with radiotherapy in the United States during 1973 -76 (Leibel et al., 1984 , patients treated at centres which had a linear accelerator had a recurrence rate of 33% compared with 42% at centres where the best equipment was a cobalt machine, a difference which just achieved statistical significance (P = 0.049). (Lustig et al., 1984 (Lustig et al., , 1991 (Gulliford et al., 1991) .
In Finland during 1979-85, 71% of the 569 patients with multiple myeloma aged up to 70 lived in districts where it was local policy to enter patients with this disease in a clinical trial; 79% of the patients from these districts were actually included in the tnals (Karjalainen & Palva, 1989) . The 5 year relative survival rate of 38% for residents of the trial disticts, irrespective of whether they were actually included in the trials, was significantly higher than the 28% survival for those from non-trial districts. The survival advantage for patients in the trial districts only obtained for the period beyond 2 years following diagnosis. (Meadows et al., 1983) . For acute non-lymphocytic leukaemia diagnosed in Britain during 1975-88, entry to a trial and treatment at a teaching hospital were both associated with a higher survival rate in an analysis allowing for age at diagnosis; these effects were largely confined to the first few months following diagnosis, but untreated children were excluded (Stiller & Eatock, 1994 (Lennox et al., 1979) . For children with medulloblastoma diagnosed during 1971-77, survival rates did not vary with the number of patients in the series at the neurological or radiotherapy centre (Stiller & Lennox, 1983 (Stiller, 1988) (Mann & Stiller, 1993) ; this analysis allowed for period of diagnosis, since survival rates and the Lennox et al. (1975) (Griffel, 1977) . In Connecticut during 1968-77, the survival rate was higher at university cancer centres for children with medulloblastoma or brain stem glioma but not for ependymoma or astrocytoma (Duffler et al., 1982) . In the Greater Delaware Valley during 1970-79, children with medulloblastoma or rhabdomyosarcoma had a significantly higher 3 year disease-free survival rate if they were treated at a specialist cancer centre, but survival did not vary between types of hospital for children with Wilms' tumour .
Although there is at first sight an impressively large number of studies of survival of cancer patients in relation to patterns of organisation of medical care, the results of different studies can hardly ever be formally pooled to produce a new, more precise estimate of the effect of the factors being investigated. Very few studies have been made of these questions in relation to any one type of cancer -in the present review, the largest number found for any site was seven. Two studies of the same site seldom ask the same questions. Studies have taken place over a period of decades and in a wide range of settings. While the effectiveness of particular treatments may be relatively constant with respect to time or geographical location, it is less safe to assume that the same will be true for the effects of patterns of organisation of care.
Sources of bias Studies of survival rates can be compromised by several types of bias. If patients with a better prognosis are selectively referred to major centres, as was found in a study of colorectal cancer at Columbia University Comprehensive Cancer Center (Neugut et al., 1991) , this could produce an artificial appearance of a better chance of survival at those centres.
Similarly, patients included in trials may have a higher survival rate than those who are not because many of the excluded patients are ineligible, often because of poor prognostic features, as was found for example in the study of stomach cancer by Ward et al. (1992) . For these reasons, more weight should be attached to studies in which some attempt was made to adjust for prognostic factors which might be confounders in any analysis of survival in relation to patterns of care. Even then, results need to be interpreted with caution. If patients at large centres undergo more thorough investigation, some may be assigned to a higher stage than if they had been treated at another hospital, as was found in the study of lung cancer by Greenberg et al. (1991) . Therefore, measures of disease severity which are likely to be the same for an individual patient regardless of where that patient is treated are preferable; these include white cell count for leukaemia and performance status (Karnofsky & Burchenal, 1949) for a wide range of cancers. Limiting the analysis to patients who survive for at least a specified short period after diagnosis, or long enough to receive a particular type of treatment, can also reduce bias by excluding many subjects who probably had little chance of remission. This approach, however, is obviously inappropriate for studying short-term mortality following surgery.
Some of the problems of referral bias which arise when patients are compared on the basis of hospital of treatment can be avoided by using instead a classification based on area of residence, as in the series of studies from Finland. Interpretation is still problematic, however, as areas coniing specialist treatment centres may be of a different socioeconomic status. Delay in diagnosis, attributable at least in part to delayed presentation, may vary between areas (Launoy et al., 1992) , and the presene of screening programmes can also affect the distribution of disease severity between areas (Pickering et al., 1992) .
There is also the possibility of publication bias, whereby studies whose conclusions point in a partiular direction are more likely to appear in journals, but for this review this has been dealt with to some extent by obtaining statements from cancer regitries whose data had been used in published studies that they had not also contributed to other studies which had remained unpublished.
Effects of hospital and protocol
Despite the limitations discussed above, there are some discernible patterns in the material reviewed here. A substantial proportion of studies reported higher survival rates for patients who were treated at major centres dealing with largr numbers of cases or at teaching hospitals and other specialist centres or for patients who were treated according to sandard protocols, usually within trials. The most obvious explanation for these results is that greater cinical experience and standardisation of treatment are likely to produce higher survival rates. There was no consistent pattern among the studies reviewed of this effect being limited to rare or common cancers, or to cancers with an especially good or poor prognosis.
Although patients treated at specialist centres or in trials frequently have higher survival rates, and there is no evidence that such treatment results in a lower survival rate, there might nevertheless be concern that improvements in survival which are often associated with more intensive therapy are counterbalanced by an increase in treatment-related morbidity. Causes of death have hardly ever been studied in relation to patterns of care. Among children with nonHodgkin's lymphoma treated in Britain during 1977-85, treatment-related mortality, at least in the medium term, was no higher at paediatric oncology centres than elsewhere (Robertson et al., 1992) .
For some tumours, particularly those with a good prognosis, non-protocol treatment can be more intensive. Among residents of the West Midlands region of England treated for parotid pleomorphic adenoma during 1977-86, the proportion of patients receiving radiotherapy, which is not now recommended for this disease, ranged from zero to 57% among the nine centres treating at least one patient a year during the study period (Parry et al., 1993) . During 1980-82, children with Wihns' tumour in Britain who were neither included in the national trial nor treated by a paediatric oncologist tended to be overtreated by comparison with current recommendations, mostly by receiving more radiotherapy than would have been given had they been included in the trial (Pritchard et al., 1989) . In both of these examples, the apparently unnecessary radiotherapy could give rise to second malignancies and other late effects.
Few studies have investigated the effect of size or type of treatment centre on the survival of patients in clinical trials or treated on protocols. In the United States, no difference was found in survival rates between major centres and local community hospitals for any of the nine cancer sites included in tnals sponsored by the Eastern Cooperative Oncology Group during 1976-81 (Begg et al., 1982) , or for five studies of the Radiation Therapy Oncology Group (Gillespie et al., 1986 (Meadows et al., 1983; Stiller & Draper, 1989) ; an unusually high survival rate was achieved at one centre in Britain during the 1970s which had only a moderate number of patients, but where there was believed to be an unusually strong emphasis for that period on strict adherence to the treatment protocol (Eden et al., 1988) . Two studies of testicular cancer found that, among men receiving protocol treatment, survival rates were higher at a single centre treating very large numbers of patients (Aass et al., 1991; Harding et al., 1993) (Matthews et al., 1986; Allum et al., 1989) . Two studies of colorectal cancer have shown wide variability in mortality between surgeons (Phillips et al., 1984; McArdle & Hole, 1991) , but this appeared to be unrelated to the number of operations performed. Studies of survival in relation to seniority of surgeon may be especially problematic since if they were to show a higher survival rate for patients operated on by consultants then this might suggest that such operations should wherever possible be carried out by consultants, but such a policy would be irreconcilable with the fact that the junior surgeons undergoing training today are the consultants of tomorrow. In studies of colorectal and bladder cancer, however, mortality was similar among patients operated on by consultants and trainee surgeons after allowance was made for disease severity (Phillips et al.. 1984; Gulliford et al., 1991) .
Rare and common cancers In the absence of formal comparative studies it has been suspected for some time, on the basis of uncontrolled comparison of national survival rates or of those from nonspecialist units, that treatment of rare cancers such as testicular tumours in specialist units results in higher survival rates (Bagshawe et al., 1985; Thornhill et al., 1988b) . It is now widely accepted that rare cancers, particularly those for which there have been substantial improvements in the effectiveness of treatment, should be treated in specialist centres. It is sometimes felt, however, that treatment of common cancers need not be organised in the same way (Kingston et al., 1992) . In the present review there are several examples of common cancers for which treatment in a specialist centre, usually a teaching hospital, apparently conferred no benefit. This is perhaps not surprising if the higher survival rate for rare cancers at specialist centres is really due to greater clincal experience, since many district hospitals will also have treated large numbers of patients with cancers of sites such as the bowel, lung and breast. Studies relating survival to the number of patients seen at a hospital rather than to the type of hospital may well sometimes be more relevant. For ovarian carcinoma, however, a relatively common cancer but one for which there have been important developments in therapy, the studies reviewed above indicate that specialist treatment is associated with higher survival.
Socioeconomic and demographic factors Changes in the provision of health care, particularly with the containment of costs as a primary objective, can give rise to anxiety over the effects on equity, i.e. the principle that outcome should as far as possible be unaffected by such factors as area of residence, social class, ethnic group or age (Pollock, 1993) . Survival rates may vary between areas as a result of delayed presentation which could be due to deficiencies in the effectiveness of screening, primary care or health education. They could also, however, vary because of differences in treatment if patients are more likely to be referred to a major centre if they live closer to that centre or are of higher socioeconomic status. Many studies have found variations in survival with social class; the relative contributions of patient-related and treatment-related factors are often unknown, but it seems likely that delayed presentation among people of low socioeconomic status accounts for much of the difference (Kogevinas et al., 1991) . In the United States, blacks have a poorer survival rate than whites for many cancer sites (Howard et al., 1992) . Part of the difference is accounted for by lower socioeconomic status and later presentation, but again the contribution of variations in patterns of care to differences in survival between ethnic groups is unknown.
The treatment of cancer in the elderly has provoked controversy (Fentiman, 1991) . Nearly all of the studies reviewed here had an upper age limit, and there is no evidence as to the effect of patterns of organisation of care on survival rates specifically for the elderly. Most trials have themselves excluded older people, often because it was felt that they would not withstand intensive treatment, with the result that there is little objective evidence as to-what is the best treatment for them. Among women enrolled in trials of breast cancer in the south-eastern United States, response rates, survival and toxicity were all similar for patients aged under or over 70 (Christman et al., 1992) . Lack of access to transport can often be a reason for undertreatment of elderly patients (Goodwin et al., 1993) .
Other outcome measures This review has concentrated on studies of survival rates that have death or, less frequently, recurrence as the end point. Survival is often both the most important and the most easily measurable outcome. For many cancers, however, particularly those of advanced stage and extremely poor prognosis, treatment is essentially palliative and substantial variations in survival rates are unlikely to occur. There are apparently no published studies of palliation and quality of life in relation to patterns of organisation of care for these patients, and this is clearly an important area for future research.
For cancers with a relatively good prognosis, quality of life as well as absolute survival is also important, though again there appears to be little published research in relation to organisational factors. A population-based study in Washington State, USA, found that women with early-stage breast cancer were less likely to receive breast-conserving surgery and radiotherapy rather than mastectomy if they lived outside the region's major urban centre and particularly if they lived in a county without its own radiotherapy facilities (Lazovich et al., 1991) . In a study of women with early-stage breast cancer treated at 19 British hospitals, however, there were no significant differences in the incidence of anxiety and depression between women who had breast-conserving surgery or mastectomy (Fallowfield et al., 1990) . The rates of psychiatric morbidity in both treatment groups were similar to those observed in a previous randomised trial of the two forms of treatment.
Conch9dow
In conclusion, referral to a specialist centre or to a hospital treating many patients with the disease, or inclusion in a clinical trial, is often linked with a higher survival rate for the cancers which have been studied; there is no evidence that centralised referral or treatment according to protocols leads to lower survival rates. Some published studies antedate the introduction of current methods of treatment, and research has also been carried out in populations covered by a wide range of health care systems. In order to establish the cancer types for which standardised referral and treatment are most beneficial, and to monitor the effects on survival of new arrangements for the organisation of medical care, further research is needed. Population-based cancer registries, covering an increasing proportion of the world's population, are an invaluable source of data for such studies. In Britain, further studies will be facilitated if the cancer registration system adopts the recommendation of the most recent national review committee that lists of patients enrolled in trials are linked with regional and national registries (Working Group of the Registrar General's Advisory Committee, 1990 
